Drug Law Weekly

Advanced BioPhotonics Inc. - Medical imaging company restructures and reduces board of directors

Antisense Therapeutics - Approval granted to restart phase IIa trial of antisense compound in MS patients

Cell Signaling Technology, Inc. - Agreement inked with AstraZeneca to evaluate PhosphoScan platform

Free University of Berlin - Report presents ethical implications of placebo-controlled trials for psychotropic drugs

GTC Biotherapeutics, Inc. - Biotherapeutics company receives notice of allowance on transgenic production patent

Georgia Institute of Technology - Portable ultrasound device makes finding veins faster

Inovio Biomedical Corporation - U.S. patents granted relating to electroporation-enabled delivery of therapeutic molecules

Lentigen Corporation - Biotech company and ZGene A/S enter license agreement for selected ZGene intellectual property

Lifeline Therapeutics, Inc. - Protandim provides a new approach to antioxidant therapy

Medicare - Canadian pharmacy criticizes AARP Medicare report

NMT Medical, Inc. - Medical technology company initiates U.S. enrollment in patent foramen ovale/migraine study

NovaDel Pharma, Inc. - U.S. grants patents for oral spray delivery of pharmaceuticals

Oriel Therapeutics, Inc. - Drug-delivery company receives third U.S. patent, first on powder metering

PDL BioPharma, Inc. - Worldwide intellectual property rights licensed for undisclosed target antigen

Palomar Medical Technologies Inc. - Trial date set in patent infringement action against Cutera

Academic Hospital Siloah, Hannover - Pancreatic duct stenting ameliorates obstruction-induced pain

Addiction Medicine - Patient flow analysis provides a more purposeful and economical treatment program

Albert Einstein College of Medicine, Bronx - Restoring fatty-acid levels in the brain may be promising treatment for obesity

Alfacell Corporation - Former HHS secretary Tommy G. Thompson named special advisor for biopharmaceutical company

Amarin Corp. plc - Promising preclinical data reported from Parkinson disease program investigating Miraxion

American Academy of Allergies, Asthma & Immunology - Study shows up to 15% of adult asthma cases in the United States are related to work

American Heart Association - Intraosseous vascular access recommended in new cardiac arrest treatment guidelines

Amicus Therapeutics - Genetic disease drug developer appoints David J. Lockhart chief scientific officer

Arkansas Epilepsy Program - Lamotrigine reported effective, well tolerated in the treatment of primary generalized tonic-clonic seizures

Array BioPharma, Inc. - Phase I trial initiated for targeted anticancer drug ARRY-334543

Attikon University Hospital, Athens - Levosimendan is a safe, effective treatment for acute heart failure syndromes

Auckland University of Technology - Docetaxel proves more effective than paclitaxel in women with node-positive breast cancer

Australia Department of Human Services - Cognitive behavioral therapy is less effective in severe cases of depression and anxiety

Australian Institute of Musculoskeletal Research - Open arthrolysis effective for treatment of postarthroplasty stiffness

Becton Dickinson & Company - U.S. FDA 510(k) grants clearance for infectious disease testing system

Berlex Biosciences - Adenovirus genome insertion sites utilize splicing machinery for therapeutic gene expression

BioDelivery Sciences International, Inc. - IND filed for BEMA LA, a treatment for moderate-to-severe pain

Biotechnology Industry Organization - Biotech group, patient groups send letter supporting U.S. FDA's Critical Path initiative

Breast Cancer - Researchers publish new studies and findings in the area of breast cancer

Brigham & Women's Hospital, Boston - Strategies for medication safety in the ambulatory chemotherapy setting outlined

CHU Bordeaux - Archived resistant HIV linked to sequences before HAART interruption

CNRS, Meylan - Piperazinobenzopyranones and phenalkylaminobenzopyranones inhibited ABCG2

CRP Sante, Luxembourg - HAART interruption and resistance mutation emergence causes virological failure

California State University - PrxII expression related to radiation-resistant MCF-7 breast cancer cells

Campbell Alliance - Pharma consultant discusses redesigning the clinical development process at meeting